Cargando…
Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital
(1) Background: COVID-19 is a novel cause of acute respiratory distress syndrome (ARDS). Indeed, with the increase of ARDS cases due to the COVID-19 pandemic, there has also been an increase in the incidence of cases with pneumothorax (PNX) and pneumomediastinum (PNM). However, the incidence and the...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658701/ https://www.ncbi.nlm.nih.gov/pubmed/34884310 http://dx.doi.org/10.3390/jcm10235608 |
_version_ | 1784612792433639424 |
---|---|
author | Tetaj, Nardi Garotto, Gabriele Albarello, Fabrizio Mastrobattista, Annelisa Maritti, Micaela Stazi, Giulia Valeria Marini, Maria Cristina Caravella, Ilaria Macchione, Manuela De Angelis, Giada Busso, Donatella Di Lorenzo, Rachele Scarcia, Silvana Farina, Anna Centanni, Daniele Vargas, Joel Savino, Martina Carucci, Alessandro Antinori, Andrea Palmieri, Fabrizio D’Offizi, Gianpiero Ianniello, Stefania Taglietti, Fabrizio Campioni, Paolo Vaia, Francesco Nicastri, Emanuele Girardi, Enrico Marchioni, Luisa |
author_facet | Tetaj, Nardi Garotto, Gabriele Albarello, Fabrizio Mastrobattista, Annelisa Maritti, Micaela Stazi, Giulia Valeria Marini, Maria Cristina Caravella, Ilaria Macchione, Manuela De Angelis, Giada Busso, Donatella Di Lorenzo, Rachele Scarcia, Silvana Farina, Anna Centanni, Daniele Vargas, Joel Savino, Martina Carucci, Alessandro Antinori, Andrea Palmieri, Fabrizio D’Offizi, Gianpiero Ianniello, Stefania Taglietti, Fabrizio Campioni, Paolo Vaia, Francesco Nicastri, Emanuele Girardi, Enrico Marchioni, Luisa |
author_sort | Tetaj, Nardi |
collection | PubMed |
description | (1) Background: COVID-19 is a novel cause of acute respiratory distress syndrome (ARDS). Indeed, with the increase of ARDS cases due to the COVID-19 pandemic, there has also been an increase in the incidence of cases with pneumothorax (PNX) and pneumomediastinum (PNM). However, the incidence and the predictors of PNX/PMN in these patients are currently unclear and even conflicting. (2) Methods: The present observational study analyzed the incidence of barotrauma (PNX/PNM) in COVID-19 patients with moderate–severe ARDS hospitalized in a year of the pandemic, also focusing on the three waves occurring during the year, and treated with positive-pressure ventilation (PPV). We collected demographic and clinical data. (3) Results: During this period, 40 patients developed PNX/PNM. The overall incidence of barotrauma in all COVID-19 patients hospitalized in a year was 1.6%, and in those with moderate–severe ARDS in PPV was 7.2% and 3.8 events per 1000 positive-pressure ventilator days. The incidence of barotrauma in moderate–severe ARDS COVID-19 patients during the three waves was 7.8%, 7.4%, and 8.7%, respectively. Treatment with noninvasive respiratory support alone was associated with an incidence of barotrauma of 9.1% and 2.6 events per 1000 noninvasive ventilator days, of which 95% were admitted to the ICU after the event, due to a worsening of respiratory parameters. The incidence of barotrauma of ICU COVID-19 patients in invasive ventilation over a year was 5.8% and 2.7 events per 1000 invasive ventilator days. There was no significant difference in demographics and clinical features between the barotrauma and non-barotrauma group. The mortality was higher in the barotrauma group (17 patients died, 47.2%) than in the non-barotrauma group (170 patients died, 37%), although this difference was not statistically significant (p = 0.429). (4) Conclusions: The incidence of PNX/PNM in moderate–severe ARDS COVID-19 patients did not differ significantly between the three waves over a year, and does not appear to be very different from that in ARDS patients in the pre-COVID era. The barotrauma does not appear to significantly increase mortality in COVID-19 patients with moderate–severe ARDS if protective ventilation strategies are applied. Attention should be paid to the risk of barotrauma in COVID-19 patients in noninvasive ventilation because the event increases the probability of admission to the intensive care unit (ICU) and intubation. |
format | Online Article Text |
id | pubmed-8658701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86587012021-12-10 Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital Tetaj, Nardi Garotto, Gabriele Albarello, Fabrizio Mastrobattista, Annelisa Maritti, Micaela Stazi, Giulia Valeria Marini, Maria Cristina Caravella, Ilaria Macchione, Manuela De Angelis, Giada Busso, Donatella Di Lorenzo, Rachele Scarcia, Silvana Farina, Anna Centanni, Daniele Vargas, Joel Savino, Martina Carucci, Alessandro Antinori, Andrea Palmieri, Fabrizio D’Offizi, Gianpiero Ianniello, Stefania Taglietti, Fabrizio Campioni, Paolo Vaia, Francesco Nicastri, Emanuele Girardi, Enrico Marchioni, Luisa J Clin Med Article (1) Background: COVID-19 is a novel cause of acute respiratory distress syndrome (ARDS). Indeed, with the increase of ARDS cases due to the COVID-19 pandemic, there has also been an increase in the incidence of cases with pneumothorax (PNX) and pneumomediastinum (PNM). However, the incidence and the predictors of PNX/PMN in these patients are currently unclear and even conflicting. (2) Methods: The present observational study analyzed the incidence of barotrauma (PNX/PNM) in COVID-19 patients with moderate–severe ARDS hospitalized in a year of the pandemic, also focusing on the three waves occurring during the year, and treated with positive-pressure ventilation (PPV). We collected demographic and clinical data. (3) Results: During this period, 40 patients developed PNX/PNM. The overall incidence of barotrauma in all COVID-19 patients hospitalized in a year was 1.6%, and in those with moderate–severe ARDS in PPV was 7.2% and 3.8 events per 1000 positive-pressure ventilator days. The incidence of barotrauma in moderate–severe ARDS COVID-19 patients during the three waves was 7.8%, 7.4%, and 8.7%, respectively. Treatment with noninvasive respiratory support alone was associated with an incidence of barotrauma of 9.1% and 2.6 events per 1000 noninvasive ventilator days, of which 95% were admitted to the ICU after the event, due to a worsening of respiratory parameters. The incidence of barotrauma of ICU COVID-19 patients in invasive ventilation over a year was 5.8% and 2.7 events per 1000 invasive ventilator days. There was no significant difference in demographics and clinical features between the barotrauma and non-barotrauma group. The mortality was higher in the barotrauma group (17 patients died, 47.2%) than in the non-barotrauma group (170 patients died, 37%), although this difference was not statistically significant (p = 0.429). (4) Conclusions: The incidence of PNX/PNM in moderate–severe ARDS COVID-19 patients did not differ significantly between the three waves over a year, and does not appear to be very different from that in ARDS patients in the pre-COVID era. The barotrauma does not appear to significantly increase mortality in COVID-19 patients with moderate–severe ARDS if protective ventilation strategies are applied. Attention should be paid to the risk of barotrauma in COVID-19 patients in noninvasive ventilation because the event increases the probability of admission to the intensive care unit (ICU) and intubation. MDPI 2021-11-29 /pmc/articles/PMC8658701/ /pubmed/34884310 http://dx.doi.org/10.3390/jcm10235608 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tetaj, Nardi Garotto, Gabriele Albarello, Fabrizio Mastrobattista, Annelisa Maritti, Micaela Stazi, Giulia Valeria Marini, Maria Cristina Caravella, Ilaria Macchione, Manuela De Angelis, Giada Busso, Donatella Di Lorenzo, Rachele Scarcia, Silvana Farina, Anna Centanni, Daniele Vargas, Joel Savino, Martina Carucci, Alessandro Antinori, Andrea Palmieri, Fabrizio D’Offizi, Gianpiero Ianniello, Stefania Taglietti, Fabrizio Campioni, Paolo Vaia, Francesco Nicastri, Emanuele Girardi, Enrico Marchioni, Luisa Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital |
title | Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital |
title_full | Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital |
title_fullStr | Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital |
title_full_unstemmed | Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital |
title_short | Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital |
title_sort | incidence of pneumothorax and pneumomediastinum in 497 covid-19 patients with moderate–severe ards over a year of the pandemic: an observational study in an italian third level covid-19 hospital |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658701/ https://www.ncbi.nlm.nih.gov/pubmed/34884310 http://dx.doi.org/10.3390/jcm10235608 |
work_keys_str_mv | AT tetajnardi incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT garottogabriele incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT albarellofabrizio incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT mastrobattistaannelisa incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT marittimicaela incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT stazigiuliavaleria incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT marinimariacristina incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT caravellailaria incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT macchionemanuela incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT deangelisgiada incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT bussodonatella incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT dilorenzorachele incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT scarciasilvana incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT farinaanna incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT centannidaniele incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT vargasjoel incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT savinomartina incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT caruccialessandro incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT antinoriandrea incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT palmierifabrizio incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT doffizigianpiero incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT ianniellostefania incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT tagliettifabrizio incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT campionipaolo incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT vaiafrancesco incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT nicastriemanuele incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT girardienrico incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT marchioniluisa incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital AT incidenceofpneumothoraxandpneumomediastinumin497covid19patientswithmoderatesevereardsoverayearofthepandemicanobservationalstudyinanitalianthirdlevelcovid19hospital |